Felodipine Tablet, Extended Release
Product Images NDC 69367-265

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Felodipine (NDC 69367-265). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Westminster Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Felodipine 01)

FDA Label Image

Principal Display Panel (2.5 mg Tablet Bottle Label)

Principal Display Panel (2.5 mg Tablet Bottle Label)
This is a description of a medication called Felodipine that comes in extended-release tablets. The tablets are film-coated and contain 25 mg of Felodipine, USP. The medication should be stored at a temperature between 20-25 degrees Celsius and should be kept in a container defined by the USP with child-resistant closure. The recommended dosage should be taken according to the package. The medication is manufactured by Vil Pharmaceutical and distributed by Westminster Pharmaceuticals. It is advised to keep the medication out of the reach of children and the tablets should not be crushed or chewed.*
FDA Label Image

Principal Display Panel (5 mg Tablet Bottle Label)

Principal Display Panel (5 mg Tablet Bottle Label)
This is a bottle of Felodipine Extended-Release tablets, USP. Each film-coated tablet contains Felodipine USP 5 mg. The bottle has 100 tablets, should be stored at 20°C to 25°C (68°F to 77°F), and protected from light. It should be kept out of reach of children in a tight, light-resistant container with a child-resistant closure. The tablets should be swallowed whole, not crushed or chewed. The usual dosage should be checked in the package insert. Manufactured by Yiling Pharmaceutical LtG located in China and distributed by Westminster Pharmaceuticals, LLC located in Nashville, TN.*
FDA Label Image

Principal Display Panel (10 mg Tablet Bottle Label)

Principal Display Panel (10 mg Tablet Bottle Label)
This text describes a medication named "Febodine, USP 10 mg" which comes in a container with the NDG code 69367-266-01. The container should be kept at room temperature and protected from light, and should be kept away from children in a child-resistant cover. The medication is distributed by Vestiminsar Pharmaceuticals, LLC in Nashville, TN, and the tablets should be swallowed whole. Information on the dosage form is not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.